CDXC: ChromaDex Corporation Stocks News on July 27, 2024

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

CDXC

Business Wire

2 days ago

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)

CDXC

Business Wire

3 days ago

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

CDXC

Business Wire

4 days ago

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August

CDXC

Business Wire

10 days ago

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August

CDXC

Simply Wall St.

14 days ago

When Will ChromaDex Corporation (NASDAQ:CDXC) Turn A Profit?

CDXC

MT Newswires

25 days ago

ChromaDex Joins Russell 2000 Index

CDXC

Business Wire

25 days ago

ChromaDex to Join Russell 2000® Index

CDXC

MT Newswires

a month ago

ChromaDex Chief Financial Officer Brianna Gerber to Resign

CDXC

MT Newswires

a month ago

ChromaDex Says Nicotinamide Riboside Shows 'Promising Effects' in Peripheral Artery Disease Trial

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

CDXC

Business Wire

a month ago

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

CDXC

Simply Wall St.

a month ago

Here's Why We Think ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Looks Fair

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)

CDXC

Business Wire

a month ago

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)

CDXC

Zacks

2 months ago

ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag

CDXC

MT Newswires

2 months ago

ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)

CDXC

Business Wire

2 months ago

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024

CDXC

Business Wire

2 months ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024

CDXC

Simply Wall St.

2 months ago

ChromaDex (NASDAQ:CDXC) shareholders are still up 82% over 1 year despite pulling back 12% in the past week

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

CDXC

Business Wire

2 months ago

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award

CDXC

Business Wire

2 months ago

ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award

CDXC

GuruFocus.com

3 months ago

ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates

CDXC

Insider Monkey

3 months ago

ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript

CDXC

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Chromadex Corp Earnings Call

CDXC

GuruFocus.com

3 months ago

ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...

CDXC

Associated Press Finance

3 months ago

ChromaDex: Q1 Earnings Snapshot

ChromaDex Corporation Reports First Quarter 2024 Financial Results

CDXC

Business Wire

3 months ago

ChromaDex Corporation Reports First Quarter 2024 Financial Results

CDXC

Simply Wall St.

3 months ago

An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued

ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement

CDXC

Business Wire

3 months ago

ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®

CDXC

Business Wire

3 months ago

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®

ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

CDXC

Business Wire

3 months ago

ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market

CDXC

Business Wire

3 months ago

ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market

CDXC

Simply Wall St.

4 months ago

Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?

CDXC

Zacks

4 months ago

Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program

CDXC

Business Wire

4 months ago

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program

ChromaDex Full Year 2023 Earnings: EPS Beats Expectations

CDXC

Simply Wall St.

5 months ago

ChromaDex Full Year 2023 Earnings: EPS Beats Expectations

CDXC

GuruFocus.com

5 months ago

ChromaDex Corp (CDXC) Reports Encouraging Fiscal Year 2023 Results with Positive Adjusted EBITDA

CDXC

Insider Monkey

5 months ago

ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript

CDXC

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Chromadex Corp Earnings Call

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results

CDXC

Business Wire

5 months ago

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results

CDXC

Simply Wall St.

5 months ago

Insiders own 26% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 44% of the company

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024

CDXC

Business Wire

5 months ago

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024

CDXC

Business Wire

6 months ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

CDXC

StockStory

6 months ago

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

CDXC

Business Wire

6 months ago

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

CDXC

Business Wire

6 months ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

Chuck Royce Adds Northwest Pipe Co to Portfolio in Recent Trade

CDXC

GuruFocus.com

6 months ago

Chuck Royce Adds Northwest Pipe Co to Portfolio in Recent Trade

CDXC

Business Wire

6 months ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

CDXC

Investor's Business Daily

6 months ago

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

CDXC

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Sterling Bancorp Inc Earnings Call

CDXC

GuruFocus.com

6 months ago

Sterling Bancorp Inc (SBT) Reports Improved Earnings for Q4 and Full Year 2023

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?

CDXC

Zacks

6 months ago

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?

CDXC

Associated Press Finance

6 months ago

Sterling Bancorp: Q4 Earnings Snapshot

Sterling Bancorp Reports Fourth Quarter and Full Year 2023 Financial Results

CDXC

Business Wire

6 months ago

Sterling Bancorp Reports Fourth Quarter and Full Year 2023 Financial Results

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

CDXC

Business Wire

6 months ago

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

CDXC

Simply Wall St.

6 months ago

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

CDXC

Simply Wall St.

6 months ago

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?

CDXC

Zacks

6 months ago

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

CDXC

GlobeNewswire

6 months ago

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

CDXC

GuruFocus.com

6 months ago

William Penn Bancorporation (WMPN) Reports Earnings Amidst Share Buyback and Declining Net Income

William Penn Bancorporation Announces Quarter End Results and Cash Dividend to Shareholders

CDXC

ACCESSWIRE

6 months ago

William Penn Bancorporation Announces Quarter End Results and Cash Dividend to Shareholders

RADCOM to Report Fourth Quarter and Full Year 2023 Results on January 31, 2024

CDXC

PR Newswire

6 months ago

RADCOM to Report Fourth Quarter and Full Year 2023 Results on January 31, 2024

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

CDXC

Business Wire

6 months ago

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

RADCOM Debuts New Generative AI Applications to Help Streamline 5G Network Operations

CDXC

PR Newswire

6 months ago

RADCOM Debuts New Generative AI Applications to Help Streamline 5G Network Operations

OFS Credit Company Provides December 2023 Net Asset Value Update

CDXC

Business Wire

6 months ago

OFS Credit Company Provides December 2023 Net Asset Value Update

Better Than BTC: 7 Crypto Stocks With the Potential to Outperform Bitcoin

CDXC

InvestorPlace

6 months ago

Better Than BTC: 7 Crypto Stocks With the Potential to Outperform Bitcoin

Butterfly Network Provides Business Update During 42nd Annual J.P. Morgan Healthcare Conference Presentation

CDXC

Business Wire

6 months ago

Butterfly Network Provides Business Update During 42nd Annual J.P. Morgan Healthcare Conference Presentation

BRAEMAR HOTELS & RESORTS DECLARES DIVIDENDS FOR THE FIRST QUARTER OF 2024

CDXC

PR Newswire

7 months ago

BRAEMAR HOTELS & RESORTS DECLARES DIVIDENDS FOR THE FIRST QUARTER OF 2024

Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3

CDXC

Business Wire

7 months ago

Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CDXC

GlobeNewswire

7 months ago

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CDXC

Business Wire

7 months ago

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Peoples Bancorp of North Carolina, Inc.'s (NASDAQ:PEBK) market cap touched US$167m last week, benefiting both individual investors who own 43% as well as institutions

CDXC

Simply Wall St.

7 months ago

Peoples Bancorp of North Carolina, Inc.'s (NASDAQ:PEBK) market cap touched US$167m last week, benefiting both individual investors who own 43% as well as institutions

3 Mortgage & Related Services Stocks to Watch Amid Ongoing Woes

CDXC

Zacks

7 months ago

3 Mortgage & Related Services Stocks to Watch Amid Ongoing Woes

Zapata AI Research in Quantum-Enhanced Generative AI Published in Nature Communications

CDXC

Business Wire

7 months ago

Zapata AI Research in Quantum-Enhanced Generative AI Published in Nature Communications

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

CDXC

Business Wire

7 months ago

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Eos Energy and Partner4Work Collaborate on Green Technology Career Development

CDXC

GlobeNewswire

7 months ago

Eos Energy and Partner4Work Collaborate on Green Technology Career Development

Euroseas Ltd. Announces Completion of Works on Retrofitting Several Items Aiming to improve the Efficiency on its Feeder Containership, M/V Synergy Busan

CDXC

GlobeNewswire

7 months ago

Euroseas Ltd. Announces Completion of Works on Retrofitting Several Items Aiming to improve the Efficiency on its Feeder Containership, M/V Synergy Busan

CDXC

Associated Press Finance

7 months ago

Conn's: Fiscal Q3 Earnings Snapshot

Conn’s, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results

CDXC

GlobeNewswire

7 months ago

Conn’s, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results

Conn’s, Inc. Announces Transformative Transaction with W.S. Badcock LLC

CDXC

GlobeNewswire

7 months ago

Conn’s, Inc. Announces Transformative Transaction with W.S. Badcock LLC

Upland Software Secures 40+ Badges in G2’s Winter 2024 Market Reports

CDXC

Business Wire

7 months ago

Upland Software Secures 40+ Badges in G2’s Winter 2024 Market Reports

Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury

CDXC

Business Wire

7 months ago

Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

CDXC

Simply Wall St.

7 months ago

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024

CDXC

GlobeNewswire

7 months ago

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

CDXC

Simply Wall St.

7 months ago

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

CDXC

GlobeNewswire

7 months ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Rocky Brands' (NASDAQ:RCKY) investors will be pleased with their favorable 40% return over the last five years

CDXC

Simply Wall St.

7 months ago

Rocky Brands' (NASDAQ:RCKY) investors will be pleased with their favorable 40% return over the last five years

Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce a Merger of Equals to Create a Premier Pennsylvania and Maryland Community Banking Franchise

CDXC

GlobeNewswire

7 months ago

Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce a Merger of Equals to Create a Premier Pennsylvania and Maryland Community Banking Franchise

Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+

CDXC

PR Newswire

7 months ago

Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+

$ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)$

CDXC

GlobeNewswire

7 months ago

ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

$Actinium's Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia$